Stanley C Gill

Title: Innovations of Stanley C Gill

Introduction

Stanley C Gill is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 7 patents to his name, Gill's work has the potential to impact the lives of many patients.

Latest Patents

One of his latest patents is focused on a pulse dosing regimen and methods of treatment for erlotinib or a pharmaceutically acceptable salt thereof. This novel dosing regimen demonstrates impressive control of central nervous system disease, surpassing the effectiveness of standard dose erlotinib. The patent describes the use of this innovative regimen for treating patients with non-small cell lung cancer (NSCLC) that harbors epidermal growth factor receptor (EGFR) mutations, including those with or without pre-existing brain metastases.

Career Highlights

Throughout his career, Stanley C Gill has worked with prominent companies such as Somalogic, Incorporated and Osi Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing innovative treatment methods.

Collaborations

Some of his notable coworkers include Larry M Gold and Sumedha D Jayasena. Their collaboration has likely fostered an environment of innovation and advancement in their respective fields.

Conclusion

Stanley C Gill's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor. His work continues to pave the way for improved patient outcomes in the medical field.